ZOM Zomedica Corp

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: ZOM

Price (delayed)

$0.1452

Market cap

$142.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$132.07M

Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will ...

Highlights
The revenue is up by 33% year-on-year and by 4.9% since the previous quarter
Zomedica's gross profit has increased by 29% YoY and by 5% from the previous quarter
ZOM's net income has dropped by 132% since the previous quarter and by 88% year-on-year
The company's EPS has shrunk by 100% QoQ and by 100% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.zomedica.com
Peers: IDXX

Key stats

What are the main financial stats of ZOM
Market
Shares outstanding
979.95M
Market cap
$142.29M
Enterprise value
$132.07M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.59
Price to sales (P/S)
5.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.24
Earnings
Revenue
$25.19M
EBIT
-$34.79M
EBITDA
-$33.96M
Free cash flow
-$27.31M
Per share
EPS
-$0.04
Free cash flow per share
-$0.03
Book value per share
$0.24
Revenue per share
$0.03
TBVPS
$0.14
Balance sheet
Total assets
$253.2M
Total liabilities
$13.18M
Debt
$2.73M
Equity
$240.02M
Working capital
$90.85M
Liquidity
Debt to equity
0.01
Current ratio
11.06
Quick ratio
10.26
Net debt/EBITDA
0.3
Margins
EBITDA margin
-134.9%
Gross margin
68.8%
Net margin
-133.6%
Operating margin
-171.7%
Efficiency
Return on assets
-12.4%
Return on equity
-13.1%
Return on invested capital
-27%
Return on capital employed
-14.3%
Return on sales
-138.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZOM stock price

How has the Zomedica stock price performed over time
Intraday
3.71%
1 week
11.69%
1 month
2.11%
1 year
-25.54%
YTD
-27.47%
QTD
-0.48%

Financial performance

How have Zomedica's revenue and profit performed over time
Revenue
$25.19M
Gross profit
$17.32M
Operating income
-$43.25M
Net income
-$33.64M
Gross margin
68.8%
Net margin
-133.6%
ZOM's net income has dropped by 132% since the previous quarter and by 88% year-on-year
The net margin has plunged by 121% from the previous quarter and by 42% YoY
The operating income has plunged by 97% YoY and by 71% from the previous quarter
Zomedica's operating margin has plunged by 63% from the previous quarter and by 48% YoY

Growth

What is Zomedica's growth rate over time

Valuation

What is Zomedica stock price valuation
P/E
N/A
P/B
0.59
P/S
5.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.24
The company's EPS has shrunk by 100% QoQ and by 100% YoY
ZOM's P/B is 82% below its 5-year quarterly average of 3.3 and 26% below its last 4 quarters average of 0.8
The equity fell by 10% YoY and by 8% QoQ
The revenue is up by 33% year-on-year and by 4.9% since the previous quarter
The P/S is 33% below the last 4 quarters average of 8.4

Efficiency

How efficient is Zomedica business performance
ZOM's return on equity has dropped by 138% since the previous quarter and by 96% year-on-year
Zomedica's ROA has plunged by 138% from the previous quarter and by 94% YoY
The ROIC has plunged by 113% from the previous quarter but it has grown by 6% YoY
The company's return on sales has shrunk by 93% QoQ and by 29% YoY

Dividends

What is ZOM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ZOM.

Financial health

How did Zomedica financials performed over time
Zomedica's quick ratio has decreased by 36% QoQ and by 31% YoY
ZOM's current ratio is down by 35% since the previous quarter and by 30% year-on-year
The debt is 99% less than the equity
The debt has soared by 57% YoY and by 56% from the previous quarter
The equity fell by 10% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.